Level C· Early human research exploring benefitsProspective StudyPubMed

A paradigm shift in diabetic wound care: Multifunctional silk fibroin-glycidyl methacrylate hydrogels delivering stem cell and immune cell secretome.

Silli EK., Wang K., Xiao Z., Liu T., Zhang L., Zhu J.

Prospective Study on Diabetic Foot, Chronic Wound, Immune Modulation, published in Int J Biol Macromol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Int J Biol Macromol (2026)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
41554360
DOI
10.1016/j.ijbiomac.2026.150363

Abstract (original English)

Chronic wounds in diabetic patients remain a significant clinical challenge due to neuropathy, vascular dysfunction, and persistent inflammation. In this study, we engineered a multifunctional wound dressing by incorporating conditioned media (CM) including secretome derived from three cell sources, natural killer (NK) cells, adipose-derived mesenchymal stem cells (ADMSCs), and umbilical cord mesenchymal stem cells (UCMSCs) into a silk fibroin-glycidyl methacrylate (SF-GMA) hydrogel scaffold. The formed SF-GMA hydrogel exhibited a porous, hydrated architecture with an optimal curing time of 15 s, a compressive modulus of 101 ± 2 KPa and favorable biocompatibility. Cytokine profiling revealed that all CM types were rich in pro-regenerative factors. In vitro assays showed that CM promoted endothelial tube formation and enhanced fibroblast and keratinocyte migration under hyperglycemic conditions. In a streptozotocin-induced diabetic mouse model, CM-loaded SF-GMA hydrogels significantly accelerated wound closure (90 ± 8.21%) compared to controls (30 ± 5.20%) by day 14. Histological analysis revealed improved re-epithelialization, granulation tissue formation, and collagen deposition, while immunofluorescence indicated enhanced neovascularization and reduced inflammation. Notably, ADMSC-CM most strongly promoted angiogenesis, whereas NK-CM enhanced epithelial migration. Overall, CM

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
AnimalsFibroinsHydrogelsWound HealingDiabetes Mellitus, ExperimentalHumansMiceMesenchymal Stem CellsMethacrylatesSecretome

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research